Woler M - Search Results

1

[The use of enoxaparine for anticoagulation in extracorporeal circulation in hemodialysis at high risk for hemorrhage].

Dechelette E, Pouzol P, Jurkovitz C, Kuentz F, Polack B, Cuzin E, Woler M. Dechelette E, et al. Among authors: woler m. J Mal Vasc. 1987;12 Suppl B:105-7. J Mal Vasc. 1987. PMID: 2834479 French.

2

Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial.

Dahan R, Houlbert D, Caulin C, Cuzin E, Viltart C, Woler M, Segrestaa JM. Dahan R, et al. Among authors: woler m. Haemostasis. 1986;16(2):159-64. doi: 10.1159/000215286. Haemostasis. 1986. PMID: 3710294 Clinical Trial.

3

The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.

Frydman AM, Bara L, Le Roux Y, Woler M, Chauliac F, Samama MM. Frydman AM, et al. Among authors: woler m. J Clin Pharmacol. 1988 Jul;28(7):609-18. doi: 10.1002/j.1552-4604.1988.tb03184.x. J Clin Pharmacol. 1988. PMID: 2851016 Clinical Trial.

4

A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.

Vinazzer H, Woler M. Vinazzer H, et al. Among authors: woler m. Haemostasis. 1986;16(2):106-15. doi: 10.1159/000215280. Haemostasis. 1986. PMID: 2423420

5

A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.

Vinazzer H, Woler M. Vinazzer H, et al. Among authors: woler m. Thromb Res. 1985 Oct 15;40(2):135-46. doi: 10.1016/0049-3848(85)90324-x. Thromb Res. 1985. PMID: 3878009

6

Comment anticiper l'évaluation de l'intérêt de santé publique des médicaments ?

Massol J, Puech A, Boissel JP; les participants à la table ronde n° 7 de Giens XXII. Massol J, et al. Therapie. 2007 Sep-Oct;62(5):417-25. doi: 10.2515/therapie:2007072. Therapie. 2007. PMID: 27393631 French. No abstract available.

7

Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high-grade lymphoma.

Laporte JP, Lesage S, Woler M, Parlier Y, Daguenel A, Najman A, Gorin NC. Laporte JP, et al. Among authors: woler m. Eur J Haematol. 1994 Aug;53(2):123-5. Eur J Haematol. 1994. PMID: 7522189 No abstract available.

8

Efficacy of recombinant human erythropoietin in the treatment of refractory anemias without excess of blasts in myelodysplastic syndromes.

Isnard F, Najman A, Jaar B, Fenaux P, Baillou C, Khoury E, Labopin M, Laporte JP, Woler M, Gorin NC, et al. Isnard F, et al. Among authors: woler m. Leuk Lymphoma. 1994 Jan;12(3-4):307-14. doi: 10.3109/10428199409059603. Leuk Lymphoma. 1994. PMID: 8167562

9

Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.

Laporte JP, Isnard F, Fenaux P, Woler M, Najman A. Laporte JP, et al. Among authors: woler m. Contrib Nephrol. 1991;88:271-2; discussion 273-5. Contrib Nephrol. 1991. PMID: 2040189 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters